Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response

CHAO YUAN HUANGHsieh F.-S.Wang C.-Y.Chen L.-J.Chang S.-S.Tsai M.-H.Hung M.-H.Kuo C.-W.Shih C.-T.Chao T.-I.Chen K.-F.2022-05-052022-05-0520180959-8049https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051279958&doi=10.1016%2fj.ejca.2018.07.010&partnerID=40&md5=f6217ab5c734f8b5ec56a212569abd39https://scholars.lib.ntu.edu.tw/handle/123456789/609454Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage responsejournal article10.1016/j.ejca.2018.07.010301030952-s2.0-85051279958